HQ Function

Prior to its acquisition, this was Zynerba's global headquarters, centralizing R&D leadership, clinical operations management, corporate strategy, and administrative functions.

Notable Features:

Located in a suburban office park, the facility provided standard corporate office amenities suitable for a clinical-stage biopharmaceutical company. No unique architectural features are widely publicized.

Work Culture:

The work culture at Zynerba's HQ was likely intensive and mission-driven, focused on advancing its novel therapies through rigorous clinical trials, with a strong emphasis on scientific innovation and addressing unmet patient needs in neuropsychiatric disorders.

HQ Significance:

It was the nerve center for Zynerba's strategic decisions, research direction, clinical development programs, and operational execution during its development of transdermal cannabinoid treatments.

Values Reflected in HQ: The headquarters likely aimed to support values of scientific dedication, patient focus, efficiency, and focused execution, all critical for a development-stage biopharmaceutical enterprise.

Location:

Prior to its acquisition, Zynerba Pharmaceuticals' global presence was primarily defined by its clinical trial activities, which enrolled patients in multiple countries as required by study protocols for its investigational therapies like Zygel. The company was focused on potential U.S. commercialization and exploring ex-U.S. partnerships but did not have established international commercial offices. Its core R&D, clinical, and corporate functions were centralized in its U.S. headquarters.

Street Address:

80 W. Lancaster Avenue, Suite 300

City:

Devon

State/Province:

PA

Country:

USA